As of May 2024 Immunomedics has a market cap of $20.30 Billion. This makes Immunomedics the world's 943th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2020 | $20.30 B | 351.86% |
2019 | $4.49 B | 65.41% |
2018 | $2.71 B | 4.65% |
2017 | $2.59 B | 567.45% |
2016 | $0.38 B | 33.8% |
2015 | $0.29 B | -35.02% |
2014 | $0.44 B | 16.82% |
2013 | $0.38 B | 73.27% |
2012 | $0.22 B | -12.06% |
2011 | $0.25 B | -6.81% |
2010 | $0.26 B | 11.66% |
2009 | $0.24 B | 89.18% |
2008 | $0.12 B | -26.69% |
2007 | $0.17 B | -17.12% |
2006 | $0.21 B | 31.74% |
2005 | $0.15 B | -2.96% |
2004 | $0.16 B | -27.73% |
2003 | $0.22 B | -1.29% |
2002 | $0.23 B | -77.11% |
2001 | $1.00 B |